New Year, New Opportunity! 2 AI Stocks Under $10 Ready to Soar

As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention.

👉 Click here to access your FREE report now!

John L. Maldonado net worth and biography

John Maldonado Biography and Net Worth

Director of Syneos Health

John L. Maldonado serves as Independent Director of the Company. Since 2006, Mr. Maldonado has been a Managing Partner at Advent, a global private equity firm, focused on buyouts in the healthcare, financial and business services sectors. Prior to joining Advent, he worked at Bain Capital, Parthenon Capital and The Parthenon Group. Mr. Maldonado currently serves on the board of directors of ATI Holdings, Inc., a provider of outpatient physical therapy, where he serves on the Audit Committee and Compliance Committee. He also currently serves on the board of directors of AccentCare, Inc., a provider in post-acute healthcare services, where he serves on the Compensation Committee and Compliance Committee, as well as the board of directors of Definitive Healthcare, LLC, a healthcare data provider, where he serves on the Compensation Committee. Mr. Maldonado previously served on the boards of Genoa, a QoL Healthcare Company, and Cotiviti Holdings, Inc. (formerly NYSE:COTV). Mr. Maldonado received his Bachelor’s degree in mathematics, summa cum laude, from Dartmouth College and his MBA, with high distinction, as a Baker Scholar from Harvard Business School.

How do I contact John L. Maldonado?: The corporate mailing address for Mr. Maldonado and other Syneos Health executives is 1030 Sync Street, Morrisville NC, 27560. Syneos Health can also be reached via phone at (919) 876-9300 and via email at [email protected]. Learn More on John L. Maldonado's contact information.
Has John L. Maldonado been buying or selling shares of Syneos Health?: John L. Maldonado has not been actively trading shares of Syneos Health during the last quarter. Most recently, John L. Maldonado sold 448,942 shares of the business's stock in a transaction on Friday, May 14th. The shares were sold at an average price of $81.04, for a transaction totalling $36,382,259.68. Learn More on John L. Maldonado's trading history.
Who are Syneos Health's active insiders?: Syneos Health's insider roster includes Michael Brooks (Insider), John Dineen (Director), Linda Harty (Director), Michelle Keefe (Insider), Donna Kralowetz (CAO), Alistair Macdonald (CEO), John Maldonado (Director), Jason Meggs (CFO), Matthew Monaghan (Director), and Jonathan Olefson (General Counsel). Learn More on Syneos Health's active insiders.

John L. Maldonado Insider Trading History at Syneos Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/14/2021	Sell	448,942	$81.04	$36,382,259.68
3/3/2021	Sell	4,654,046	$74.17	$345,190,591.82

John L. Maldonado Buying and Selling Activity at Syneos Health

Syneos Health Company Overview

Syneos Health, Inc., operates as an integrated biopharmaceutical solutions company. The company operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in Phase I to IV of clinical development. This segment offers individual services, including regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health services, clinical trial diversity, biometrics, and regulatory affairs. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication; and consulting services. Its customers include companies in the biopharmaceutical, biotechnology, and medical device industries. It operates in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. The company has a strategic partnership with uMotif Limited to deliver patient-centric eClinical platform. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina. As of September 28, 2023, Syneos Health, Inc. was taken private.

Today's Range

Now: $42.98

$42.97

$42.99

50 Day Range

MA: $42.86

$42.48

$42.98

2 Week Range

Now: $42.98

$22.89

$52.23

Volume

7,386,200 shs

Average Volume

1,924,736 shs

Market Capitalization

$4.46 billion

P/E Ratio

62.29

Dividend Yield

N/A

Beta

1.58